Role of Advanced Analytics -Mass Spectrometry in Monoclonal Antibody (mAb) Stability Assessment

Friday, 12 October 2018 at 10:00

Add to Calendar ▼2018-10-12 10:00:002018-10-12 11:00:00Europe/LondonRole of Advanced Analytics -Mass Spectrometry in Monoclonal Antibody (mAb) Stability AssessmentPharmaAQ in MumbaiMumbaiSELECTBIOenquiries@selectbiosciences.com

Ravi Krovidi, Lead Investigator - Biopharmaceutical Development, Syngene International Ltd

Ravi Krovidi

Currently, Dr Ravi Krovidi is a Lead Investigator, Biopharmaceutical Development. He is Head of Advanced Analytics. He has 16 years of industrial experience (USA, India). He Led teams in creating biosimilarity assessment sections of dossiers for several biosimilars. Dr Krovidi is expertise in advanced protein analytics as per ICH Q6B guidelines, scientific partnering from early inception to completion. He is also Expertise in developing and validating client specific methods. He has published and presented at various Indian and international conferences.